Sabbagh et al., 2015 - Google Patents
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementiaSabbagh et al., 2015
View PDF- Document ID
- 12899662350854011325
- Author
- Sabbagh M
- Chen K
- Rogers J
- Fleisher A
- Liebsack C
- Bandy D
- Belden C
- Protas H
- Thiyyagura P
- Liu X
- Roontiva A
- Luo J
- Jacobson S
- Malek-Ahmadi M
- Powell J
- Reiman E
- Publication year
- Publication venue
- Alzheimer's & Dementia
External Links
Snippet
Introduction Down syndrome (DS) is associated with amyloid b (Ab) deposition. Methods We characterized imaging measurements of regional fibrillar Ab burden, cerebral metabolic rate for glucose (rCMRgl), gray matter volumes (rGMVs), and age associations in 5 DS with …
- 201000010374 Down syndrome 0 title abstract description 188
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4806—Functional imaging of brain activation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sabbagh et al. | Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia | |
| Croteau et al. | A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease | |
| Whitwell et al. | Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease | |
| Kantarci et al. | Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease | |
| Riese et al. | Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype | |
| McDonald et al. | Diffusion tensor imaging correlates of memory and language impairments in temporal lobe epilepsy | |
| Abe et al. | Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression | |
| Handen et al. | Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B | |
| Burggren et al. | Specificity of brain activation patterns in people at genetic risk for Alzheimer disease | |
| Nabeyama et al. | Functional MRI study of brain activation alterations in patients with obsessive–compulsive disorder after symptom improvement | |
| Irwin et al. | Amygdalar interhemispheric functional connectivity differs between the non-depressed and depressed human brain | |
| Rodrigue et al. | Differential effects of age and history of hypertension on regional brain volumes and iron | |
| Lao et al. | Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population | |
| Thomas et al. | Impact of time-of-day on diffusivity measures of brain tissue derived from diffusion tensor imaging | |
| Hendry et al. | White matter abnormalities in autism detected through transverse relaxation time imaging | |
| Travis et al. | Abnormal white matter properties in adolescent girls with anorexia nervosa | |
| Bozzali et al. | Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer's disease | |
| Nakamae et al. | Alteration of fractional anisotropy and apparent diffusion coefficient in obsessive–compulsive disorder: a diffusion tensor imaging study | |
| Cormack et al. | Extra-hippocampal grey matter density abnormalities in paediatric mesial temporal sclerosis | |
| Chen et al. | Reduced cerebral glucose uptake in an Alzheimer’s rat model with glucose-weighted chemical exchange saturation transfer imaging | |
| US20230389854A1 (en) | Neuromelanin-sensitive mri and methods of use thereof | |
| Whitwell et al. | Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease | |
| Schröder et al. | Patterns of cortical activity and memory performance in Alzheimer’s disease | |
| Switzer et al. | Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy | |
| van Bergen et al. | Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old |